Iovance Biotherapeutics Obtains License to Develop and Commercialize a Novel IL-2 Analog
January 12, 2020 16:30 ET
|
Iovance Biotherapeutics, Inc.
SAN CARLOS, Calif., Jan. 12, 2020 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, today...
Agios Announces “Agios 2025” Strategic Vision and Highlights 2020 Milestones
January 12, 2020 16:00 ET
|
Agios Pharmaceuticals, Inc.
– In 2025, Company Expects to Have 4 Marketed Products in at Least 8 Indications, at Least 6 Molecules in Clinical Development and a Broad Research Pipeline – – Broadening Opportunities for PKR...
BioCryst to Provide Berotralstat and BCX9930 Program Updates at 38th Annual J.P. Morgan Healthcare Conference
January 12, 2020 16:00 ET
|
BioCryst Pharmaceuticals, Inc.
RESEARCH TRIANGLE PARK, N.C., Jan. 12, 2020 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will provide updates on berotralstat, an oral...
Iovance Biotherapeutics and Cellectis Enter into a Research Collaboration and Exclusive Worldwide License Agreement
January 12, 2020 16:00 ET
|
Iovance Biotherapeutics, Inc.
SAN CARLOS, Calif. and NEW YORK, Jan. 12, 2020 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer...
Atara Biotherapeutics to Present 2020 Key Milestones and Progress in Bringing Off-The-Shelf, Allogeneic T-Cell Immunotherapies to Patients in Need at the 38th Annual J.P. Morgan Healthcare Conference
January 12, 2020 14:00 ET
|
Atara Biotherapeutics, Inc.
Key milestones anticipated across Atara’s four strategic priorities in 2020 Continued investment in EBV T-cell platform to develop off-the-shelf, allogeneic CAR T immunotherapies leveraging favorable...
Manhattan Associates and IHL Group Survey Reveals the Key to Maximizing Omnichannel Profits
January 12, 2020 10:53 ET
|
Manhattan Associates, Inc.
NEW YORK, Jan. 12, 2020 (GLOBE NEWSWIRE) -- A recent survey by Manhattan Associates Inc. (NASDAQ: MANH) and IHL Group has uncovered a strong correlation between omnichannel fulfillment maturity and...
Teladoc Health to Acquire InTouch Health
January 12, 2020 10:30 ET
|
Teladoc Health, Inc.
Acquisition creates clear leader in providing virtual care solutions for both hospitals & health systems Combination broadens advanced clinical use cases to be enabled for expanded care...
Patientco Achieves HFMA Peer Review Designation
January 12, 2020 10:00 ET
|
Healthcare Financial Management Association
Chicago, IL, Jan. 12, 2020 (GLOBE NEWSWIRE) -- The Healthcare Financial Management Association (HFMA) recently reviewed Patientco’s billing and payment platform using the Peer Review process. After...
SATO America Releases Three New Products to Innovate Retail Printing at NRF 2020
January 12, 2020 09:00 ET
|
SATO America
Charlotte, NC, Jan. 12, 2020 (GLOBE NEWSWIRE) -- SATO America, an industry-leading global provider of auto-ID solutions, will be unveiling three new products at this year’s National Retail...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aurora Cannabis Inc. - ACB
January 12, 2020 09:00 ET
|
Pomerantz LLP
NEW YORK, Jan. 12, 2020 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Aurora Cannabis Inc. (“Aurora” or the “Company”) (NYSE: ACB). Such investors are advised...
- May 03, 2024 19:15 ET GDRX Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Against GoodRx Holdings, Inc.
- May 03, 2024 19:13 ET ADSK Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Against Autodesk, Inc.